Mifegyne debate flares over legislative void and safety nets
Discussions on introducing Mifegyne, an oral abortion pill, have resumed following instructions from President Lee Jae-myung, but concerns are mounting over the lack of legal standards and medical safety nets. Prescription criteria, the scope of medical personnel liability, and post-ingestion emergency response systems are expected to emerge as central point..